Kepos Capital’s Silexion Therapeutics Warrant SLXNW Stock Holding History

Kepos Capital’s Portfolio SLXNW Stock Details SLXNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2K	Hold	100,000	–	–	﹤0.01%	144
2025 Q4	$3K	Hold	100,000	–	–	0.02%	32
2025 Q3	$4K	Hold	100,000	–	–	0.02%	38
2025 Q2	$4K	Hold	100,000	–	–	0.01%	44
2025 Q1	$8K	Hold	100,000	–	–	0.01%	48
2024 Q4	$3K	Hold	100,000	–	–	﹤0.01%	53
2024 Q3	$3K	Buy	+100,000	New	+$5.79K	﹤0.01%	216

Other funds holding SLXNW

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

PMAM

Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.39% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Kepos Capital's SLXNW Position: Q1 2026 in Review

Kepos Capital held its Silexion Therapeutics Warrant (SLXNW) position steady in Q1 2026 at 100,000 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #144.

Kepos Capital first reported a position in SLXNW in Q3 2024 and has held it in 7 quarters since. The position peaked at $8K in Q1 2025. 19 funds tracked by Wall St. Rank hold SLXNW as of Q1 2026.

Kepos Capital held 100,000 shares of Silexion Therapeutics Warrant worth $2K as of Q1 2026.
Kepos Capital left its Silexion Therapeutics Warrant share count unchanged in Q1 2026.
Silexion Therapeutics Warrant made up ﹤0.01% of Kepos Capital's portfolio in Q1 2026, its #144 holding.
Kepos Capital first reported a position in Silexion Therapeutics Warrant in Q3 2024 and has held it in 7 quarters since.
Kepos Capital's Silexion Therapeutics Warrant position peaked at $8K in Q1 2025.
19 funds tracked by Wall St. Rank held Silexion Therapeutics Warrant as of Q1 2026.

Based on Kepos Capital's 13F filing for Q1 2026, filed 12 May 2026.